IP
iQure Pharma Inc.
SEC filingOther · Skillman, NJ
Amount raised$2.8Msold at filing
Total offering$4M$1.2M still open
Investors in the raise18count reported to the SEC
FiledSep 21, 2026first sale Sep 9, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Pawel ZolnierczykExecutive Officer
Executive officers, directors and promoters as listed on the Form D.